Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03906331
Title	Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Recruitment	Available
Gender	both
Phase	Expanded access
Variant Requirements	Yes
Sponsors	Loxo Oncology, Inc.
Indications	Advanced Solid Tumor
Therapies	Selpercatinib
Age Groups:	child \| senior \| adult
Covered Countries	USA \| POL \| NZL \| ITA \| ISR \| FRA \| ESP \| DEU \| CHE \| AUS